OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Company Overview - OraSure Technologies, Inc. is focused on transforming health through actionable insights and improving access, quality, and value of healthcare with innovative testing solutions [4] - The company, along with its subsidiaries, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection devices [4] Product Update - The OraQuick HIV Self-Test has expanded its approved age range to include individuals aged 14 and older, previously limited to those 17 and older [1] - This change aims to increase access to HIV testing for adolescents, addressing a significant gap in testing among young people [1][3] Market Context - According to the CDC, 19% of new HIV diagnoses in the U.S. are among individuals aged 13 to 24, with only 6% of high school students having ever been tested for HIV [2] - Nearly half of young people with HIV are unaware of their status, highlighting the need for increased testing options [2] Company Commitment - OraSure is dedicated to promoting HIV testing and reducing the stigma associated with infection, providing educational materials and care linkage information with its products [3] - The OraQuick HIV Self-Test has been available to consumers in the U.S. since 2012, reflecting the company's long-term commitment to improving access to critical health information [3]